Cipla Limited, one of India’s largest global pharmaceutical companies, has announced the re-appointment of Shri P R Ramesh as an Independent Director on its Board. A former Executive Chairman of Deloitte India, Ramesh brings nearly four decades of expertise in auditing, financial reporting, and corporate governance. His re-appointment, effective from early 2026, underscores Cipla’s commitment to maintaining a robust regulatory and financial oversight framework as it navigates the complex global pharmaceutical landscape.
Trending
- Pernod Ricard India Appoints Sonia Arora as Director of Consumer Insights
- PM Narendra Modi Becomes India’s Longest-Serving Head of Government
- Whole-time Director Indirakumar Resigns from Indrayani Biotech Board
- Secretary Debashree Mukherjee Assigned Additional Charge as Chairperson, NCVET
- Chief Growth Officer Amber Faulkner Joins Droga5 London
- Minister Laljit Singh Bhullar Resigns from Punjab Cabinet Following Official’s Suicide
- Sagarsoft (India) Appoints Finance Veteran Kanakadhara Srinivasan to its Board
- IAS Pramod Kumar Meherda Assigned Additional Charge as CEO, NRAA

